Insider Trading Activity Array Biopharma Inc (NASDAQ:ARRY) – Director Sold 21,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For Array Biopharma Inc (NASDAQ:ARRY)

Lunsen Gil J Van , Director of Array Biopharma Inc (NASDAQ:ARRY) reportedly Sold 21,500 shares of the company’s stock at an average price of 17.16 for a total transaction amount of $368,940.00 SEC Form

Insider Trading History For Array Biopharma Inc (NASDAQ:ARRY)

  • On 7/23/2013 John R Moore, VP, sold 5,000 with an average share price of $6.50 per share and the total transaction amounting to $32,500.00.
  • On 8/2/2013 John R Moore, VP, sold 75,384 with an average share price of $7.02 per share and the total transaction amounting to $529,195.68.
  • On 9/6/2013 Liam Ratcliffe, Director, sold 577,286 with an average share price of $5.79 per share and the total transaction amounting to $3,342,485.94.
  • On 9/16/2013 Liam Ratcliffe, Director, sold 1,673,172 with an average share price of $6.08 per share and the total transaction amounting to $10,172,885.76.
  • On 3/2/2015 Ron Squarer, CEO, sold 40,000 with an average share price of $8.25 per share and the total transaction amounting to $330,000.00.
  • On 3/2/2015 Andrews R Robbins, SVP, sold 21,576 with an average share price of $8.25 per share and the total transaction amounting to $178,002.00.
  • On 3/3/2015 Kyle Lefkoff, Director, sold 70,000 with an average share price of $8.00 per share and the total transaction amounting to $560,000.00.

    • Analyst Ratings History For Array Biopharma Inc (NASDAQ:ARRY)

    • On 9/11/2017 JPMorgan Chase & Co. Reiterated Rating Buy with a price target of $14.00
    • On 9/11/2017 Cowen Reiterated Rating Outperform with a price target of $14.00 to $15.00
    • On 9/20/2017 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $14.00 to $18.00
    • On 12/22/2017 Jefferies Group Boost Price Target of rating Buy with a price target of $13.00
    • On 1/21/2018 Cantor Fitzgerald Reiterated Rating Buy with a price target of $15.00
    • On 2/6/2018 SunTrust Banks Reiterated Rating Buy with a price target of $20.00
    • On 2/7/2018 Stifel Nicolaus Boost Price Target of rating Buy to Buy with a price target of $20.00 to $23.00

    Recent Trading Activity for Array Biopharma Inc (NASDAQ:ARRY)
    Shares of Array Biopharma Inc closed the previous trading session at with shares trading hands.